SEARCH RESULTS FOR: "Tag: BIIB"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2019(14)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(3)
Analyst Downgrades(4)
Analyst Update(12)
Analyst Upgrades(5)
Buzz Stocks(21)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(11)
Market Recap(1)
Midday Market Check(5)
Opening View(6)
Quantitative Analysis(2)
Stock Market News(5)
Stocks On the Move(12)
Technical Analysis(1)

10/30/2019 9:14 AM
U.S stock futures are pointing to a higher open ahead of a huge day on Wall Street. Investors are gearing up for the Fed's rate-cut decision this afternoon, and the subsequent press conference from...
10/22/2019 12:58 PM
The shares of Biogen Inc (NASDAQ:BIIB) have skyrocketed today, after the company surprised investors with plans to submit its Alzheimer's treatment for regulatory approval in the U.S. Biogen disconti...
10/17/2019 9:49 AM
BofA-Merrill Lynch resumed coverage on Biogen Inc (NASDAQ:BIIB) with an "underperform" rating and a $200 price target -- a more than 12% discount to last night's close. The brokerage firm cited incre...
7/5/2019 3:06 PM
It was a solid week for stocks, with the Fourth of July holiday offering an abbreviated start to the new month. The Dow, S&P 500, and Nasdaq used early-week trade truce momentum to nab weekly wins,...
7/1/2019 10:23 AM
The shares of Biogen Inc (NASDAQ:BIIB) are up 0.9% at $236 after the firm said its spinal muscular atrophy treatment Spinraza was well tolerated in patients with the disease, with many seeing "unprec...
Partner Center